Détail du document
Identifiant

oai:pubmedcentral.nih.gov:1074...

Sujet
Review
Auteur
Wang, Ji Ford, James C. Mitra, Anirban K.
Langue
en
Editeur

MDPI

Catégorie

Biology

Année

2023

Date de référencement

25/03/2024

Mots clés
cancer metastasis establish metastasis-initiating mics ovarian cells
Métrique

Résumé

SIMPLE SUMMARY: Metastasis is the main cause of poor outcomes in ovarian cancer and metastasis-initiating cells are a subpopulation of cancer cells that can effectively establish metastases.

We provide an overview of their characteristics, function, and the potential of targeting them in ovarian cancer.

ABSTRACT: Ovarian cancer is the deadliest gynecological malignancy with a high prevalence of transcoelomic metastasis.

Metastasis is a multi-step process and only a small percentage of cancer cells, metastasis-initiating cells (MICs), have the capacity to finally establish metastatic lesions.

These MICs maintain a certain level of stemness that allows them to differentiate into other cell types with distinct transcriptomic profiles and swiftly adapt to external stresses.

Furthermore, they can coordinate with the microenvironment, through reciprocal interactions, to invade and establish metastases.

Therefore, identifying, characterizing, and targeting MICs is a promising strategy to counter the spread of ovarian cancer.

In this review, we provided an overview of OC MICs in the context of characterization, identification through cell surface markers, and their interactions with the metastatic niche to promote metastatic colonization.

Wang, Ji,Ford, James C.,Mitra, Anirban K., 2023, Defining the Role of Metastasis-Initiating Cells in Promoting Carcinogenesis in Ovarian Cancer, MDPI

Partager

Source

Articles recommandés par ES/IODE IA

High-Frequency Repetitive Magnetic Stimulation at the Sacrum Alleviates Chronic Constipation in Parkinson’s Patients
magnetic stimulation parkinson’s significant patients scale sacrum pd hf-rms chronic constipation scores
The mechanism of PFK-1 in the occurrence and development of bladder cancer by regulating ZEB1 lactylation
bladder cancer pfk-1 zeb1 lactylation glycolysis inhibits lactate glucose bc pfk-1 cancer lactylation cells bladder